Scientists test new drug cocktail in fight against tough pancreatic cancer
NCT ID NCT00885066
Summary
This early-stage study aimed to find the safest and most effective dose of a three-drug combination for treating advanced pancreatic cancer. It involved 30 patients whose cancer had progressed after initial treatment. The main goal was to understand the side effects and determine the best dose for future research, not to cure the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
Conditions
Explore the condition pages connected to this study.